Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-24 @ 3:43 PM
NCT ID:
NCT06100692
Eligibility Criteria:
Inclusion Criteria:
* Selection of patients
1. All adults (18 years or older ), who were confirmed based on pathology ( Head and Neck Squamous Cell Carcinomas ), will administere chemo-radiotherapy either as preoperative (neoadjuvant), postoperative (adjuvant) therapy or definitive therapy, no randomization .
2. The treatment group will receive combined oral Vit D and Zinc and the control group will take placebo capsules or receive no treatment.
3. No documentation of any other causes of oral mucositis in their medical records as : immunocomprmized patients d.t HIV
Exclusion Criteria:
1. Non Head and Neck cancer
2. patients with any other causes of oral mucositis
3. Double malignancy
4. Un eligible patients for radiotherapy ( comatosed, bedridden and sever chest disease )
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06100692
Study Brief:
Protocol Section:
NCT06100692